EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
About this episode
Dr Suresh S Ramalingam and Dr Helena Yu discuss therapy selection for EGFR mutation-positive non-small cell lung cancer and summarize recent treatment advances.
Dr Suresh S Ramalingam and Dr Helena Yu discuss the selection and sequencing of therapy for patients with EGFR mutation-positive non-small cell lung cancer and summarize major advances in the treatment landscape reported over the past year. CME information and select publications here .
More episodes of Oncology Today with Dr Neil Love
- Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
- Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
- Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
- Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
- HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making
- Metastatic Bladder Cancer — Rapid Case Review Issue 4
Explore listener stats, chart rankings, contacts and more on the Oncology Today with Dr Neil Love podcast page.